Cannabis Strategic Ventures (Cannabis Strategic Ventures) Risk Assessment

View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Cannabis Strategic Ventures is: No Data: Cannot be evaluated.

Competitive Comparison of Cannabis Strategic Ventures's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Strategic Ventures's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's Risk Assessment falls into.

Cannabis Strategic Ventures (OTCPK:NUGS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Cannabis Strategic Ventures Risk Assessment Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212

Website

https://www.cannabisstrategic.com

Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.

Executives

Gordon Samson	director, officer: Chief Financial Officer	9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown	director, officer: VP, Corporate Development	9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster	director, officer: CFO, Secretary & Treasurer	5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler	director, 10 percent owner, officer: President	#604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman	director, 10 percent owner, officer: SECRETARY/TREASURER	5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall	director, 10 percent owner, officer: President	2435 WEST 7TH AVENUE VANCOUVER A1 00000